Holen Sie sich die Stockscreener-App
0.63
1.61%
0.01
Finanzdaten der Cyclo Therapeutics Inc-Aktie (CYTH)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
34.99%
0.2025
|
0.3114 | 0.4955 | 0.1171 | 0.1524 |
| Cost Of Revenue |
0.0118
|
- | - | - | - |
| Gross Profit |
0.1906
|
- | - | - | - |
Operating Expenses
|
9.50%
5.3117
|
5.8696 | 5.2629 | 4.7501 | 5.1595 |
| Benefits Costs and Expenses |
23.65%
4.5455
|
5.9538 | 5.2668 | 4.7536 | 5.1595 |
| Costs And Expenses |
9.50%
5.3117
|
5.8696 | 5.2629 | 4.7501 | 5.1595 |
| Operating Income/Loss |
9.24%
-5.1211
|
-5.6425 | -4.7675 | -4.6329 | -5.0071 |
| Nonoperating Income/Loss |
682.36K%
0.778
|
0.000114 | -0.00389 | -0.00351 | 0.000047 |
| Income/Loss From Continuing Operations Before Tax |
23.03%
-4.3431
|
-5.6424 | -4.7714 | -4.6365 | -5.0071 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
23.03%
-4.3431
|
-5.6424 | -4.7714 | -4.6365 | -5.0071 |
|
Net Income/Loss
|
23.03%
-4.343
|
-5.6423 | -4.771 | -4.6365 | -5.0071 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,377%
28.59
|
1.9348 | 16.19 | 14.04 | 11.00 |
| Basic Earnings Per Share |
34.78%
-0.15
|
-0.23 | -0.29 | -0.33 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.61%
1.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):